Daan Gene Co., Ltd. (SHE:002030)
5.55
+0.11 (2.02%)
Jun 18, 2026, 3:04 PM CST
Daan Gene Revenue
Daan Gene had revenue of 149.44M CNY in the quarter ending March 31, 2026, a decrease of -11.65%. This brings the company's revenue in the last twelve months to 737.96M, down -10.43% year-over-year. In the year 2025, Daan Gene had annual revenue of 757.66M, down -11.18%.
Revenue (ttm)
737.96M
Revenue Growth
-10.43%
P/S Ratio
10.55
Revenue / Employee
490.02K
Employees
1,506
Market Cap
7.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 757.66M | -95.36M | -11.18% |
| Dec 31, 2024 | 853.02M | -327.87M | -27.76% |
| Jan 1, 2024 | 1.18B | -10.87B | -90.20% |
| Jan 1, 2023 | 12.05B | 4.38B | 57.17% |
| Jan 1, 2022 | 7.66B | 2.32B | 43.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 15.60B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.84B |
| Aurisco Pharmaceutical | 1.68B |
| Nanjing Vazyme Biotech | 1.41B |
| Chengdu Easton Biopharmaceuticals | 1.35B |
| Liaoning Chengda Biotechnology | 1.31B |
| Shanghai Medicilon | 1.26B |
| GemPharmatech | 830.61M |